MetLife Investment Management’s Cardlytics CDLX Stock Holding History

MetLife Investment Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,577	Closed	-$95.6K	–	2789
2024 Q4	$95.6K	Buy	2,577 +2,047	+386%	+$78.3K	﹤0.01%	2643
2024 Q3	$17K	Sell	530 -1,787	-77%	-$99.2K	﹤0.01%	2829
2024 Q2	$190K	Buy	2,317 +515	+29%	+$55.7K	﹤0.01%	2274
2024 Q1	$261K	Hold	1,802	–	–	﹤0.01%	2048
2023 Q4	$166K	Hold	1,802	–	–	﹤0.01%	2342
2023 Q3	$297K	Hold	1,802	–	–	﹤0.01%	1962
2023 Q2	$114K	Buy	+1,802	New	+$109K	﹤0.01%	2599
2023 Q1	–	Sell	-1,748	Closed	-$101K	–	2795
2022 Q4	$101K	Hold	1,748	–	–	﹤0.01%	2589
2022 Q3	$164K	Hold	1,748	–	–	﹤0.01%	2418
2022 Q2	$390K	Hold	1,748	–	–	﹤0.01%	1837
2022 Q1	$961K	Buy	1,748 +646	+59%	+$390K	0.01%	1352
2021 Q4	$728K	Hold	1,102	–	–	0.01%	1291
2021 Q3	$925K	Hold	1,102	–	–	0.01%	1154
2021 Q2	$1.4M	Hold	1,102	–	–	0.01%	1012
2021 Q1	$1.21M	Buy	1,102 +57	+5%	+$75.3K	0.01%	1066
2020 Q4	$1.49M	Sell	1,045 -106	-9%	-$113K	0.01%	953
2020 Q3	$812K	Hold	1,151	–	–	0.01%	1134
2020 Q2	$805K	Buy	1,151 +487	+73%	+$281K	0.01%	1113
2020 Q1	$232K	Hold	664	–	–	﹤0.01%	1610
2019 Q4	$418K	Hold	664	–	–	﹤0.01%	1557
2019 Q3	$223K	Hold	664	–	–	﹤0.01%	1882
2019 Q2	$173K	Buy	+664	New	+$133K	﹤0.01%	2116

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MetLife Investment Management's CDLX Position: Q1 2025 in Review

MetLife Investment Management sold out of Cardlytics (CDLX) in Q1 2025, closing a stake of 2,577 shares — an estimated $95.6K sold.

MetLife Investment Management first reported a position in CDLX in Q2 2019 and held it in 22 quarters. The position peaked at $1.49M in Q4 2020. 108 funds tracked by Wall St. Rank hold CDLX as of Q1 2025.

MetLife Investment Management reported no remaining Cardlytics position as of Q1 2025 after selling out during the quarter.
MetLife Investment Management sold 2,577 Cardlytics shares in Q1 2025, an estimated $95.6K.
MetLife Investment Management first reported a position in Cardlytics in Q2 2019 and held it in 22 quarters.
MetLife Investment Management's Cardlytics position peaked at $1.49M in Q4 2020.
108 funds tracked by Wall St. Rank held Cardlytics as of Q1 2025.

Based on MetLife Investment Management's 13F filing for Q1 2025, filed 14 May 2025.